Filtros de búsqueda

Lista de obras de

21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

artículo científico publicado en 2017

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology

artículo científico publicado en 2017

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

article

A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer

scientific article published on 21 August 2019

A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer

artículo científico publicado en 2010

A roundtable discussion of aromatase inhibitors as therapy for breast cancer.

artículo científico publicado en 2003

Accelerated partial breast irradiation after conservative surgery for breast cancer

artículo científico publicado en 2004

Accuracy of a Preoperative Model for Predicting Invasive Breast Cancer in Women with Ductal Carcinoma-in-situ on Vacuum-Assisted Core Needle Biopsy

article

Age and lymph node status in breast cancer: not a straightforward relationship

artículo científico publicado en 2009

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

artículo científico publicado en 2015

Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer

artículo científico publicado en 2010

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.

artículo científico publicado en 2008

American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting ⬇️

artículo científico publicado el 5 de mayo de 2003

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

artículo científico publicado en 2010

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

artículo científico publicado en 2004

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

artículo científico publicado en 2002

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

artículo científico publicado en 2015

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

artículo científico publicado en 2017

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

artículo científico publicado en 2005

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

artículo científico publicado en 2010

Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.

artículo científico publicado en 2017

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

artículo científico publicado en 2008

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

article by Harry D. Bear et al published March 2013 in Obstetrical and Gynecological Survey

Bevacizumab added to neoadjuvant chemotherapy for breast cancer

artículo científico publicado en 2012

Biomarker data from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.

scientific article published in 2020

Can we approach zero relapse in breast cancer?

scientific article published on 01 October 2005

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

scientific article published on 08 January 2020

Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers

scientific article published on 01 July 2019

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

artículo científico publicado en 2014

Circulating Tumor Cells in Patients Receiving Neoadjuvant Chemotherapy: Refining the Paradigm of Prognosis and Treatment Individualization

artículo científico publicado en 2018

Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles

artículo científico publicado en 2020

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ

artículo científico publicado en 2016

Clinical relevance of the 21-gene Recurrence Score assay in treatment decisions for patients with node-positive breast cancer in the genomic era

article

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

artículo científico publicado en 2021

Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.

artículo científico publicado en 2011

Continuing evolution in breast cancer surgical management

artículo científico publicado en 2005

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen

artículo científico publicado en 2004

Current approach of the axilla in patients with early-stage breast cancer

artículo científico

Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

scientific article published on 01 January 2019

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial

artículo científico publicado en 2013

Drug development: neoadjuvant opportunities in breast cancer

artículo científico publicado en 2013

Early-stage breast cancer: new developments and controversies. Preface

artículo científico publicado en 2010

Effect of occult metastases on survival in node-negative breast cancer

artículo científico publicado en 2011

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

artículo científico publicado en 2018

Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II T

artículo científico publicado en 2016

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

artículo científico publicado en 2004

Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving Surgery (BCS).

artículo científico

Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings

artículo científico publicado en 2008

Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.

artículo científico publicado en 2011

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer

artículo científico publicado en 2008

Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer

artículo científico publicado en 2015

Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer

artículo científico publicado en 2011

Incorporating the Oncotype DX breast cancer assay into community practice: An expert Q & A and case study sampling.

artículo científico publicado en 2008

Incorporating the Oncotype DX breast cancer assay into community practice: an expert Q&A and case study sampling.

artículo científico publicado en 2008

Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial

artículo científico publicado en 2015

Is sentinel node biopsy necessary in conservatively treated DCIS?

artículo científico publicado en 2007

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

artículo científico publicado en 2013

Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization

artículo científico publicado en 2013

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Pa

artículo científico publicado en 2017

Long-term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature

artículo científico publicado en 2006

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

artículo científico publicado en 2011

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

scientific article published on 05 December 2019

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer

artículo científico publicado en 2010

Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and

artículo científico publicado en 2006

Lumpectomy margins: everything old is new again?

artículo científico publicado en 2014

Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations

artículo científico publicado en 2020

Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline

artículo científico publicado en 2020

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial

artículo científico publicado en 2011

Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy

artículo científico publicado en 2012

Metaplastic breast carcinoma: Current therapeutic approaches and novel targeted therapies

scientific article published on 27 June 2019

Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).

artículo científico publicado en 2017

Molecular Predictive and Prognostic Markers in Locoregional Management

scientific article published on 22 May 2020

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

artículo científico publicado en 2010

NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response

scientific article published on 05 May 2020

NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging dise

artículo científico publicado en 2006

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2 ⬇️

artículo científico publicado en 2019

NSABP B-47: A phase III trial of adjuvant therapy comparing chemotherapy alone (six cycles of docetaxel plus cyclophosphamide or four cycles of doxorubicin plus cyclophosphamide followed by weekly paclitaxel) to chemotherapy plus trastuzumab in wome

artículo científico publicado en 2012

NSABP B-47: A randomized phase III trial of adjuvant therapy comparing chemotherapy alone to chemotherapy plus trastuzumab in women with node-positive or high-risk node-negative HER2-low invasive breast cancer.

scientific article published in 2013

NSABP breast cancer clinical trials: recent results and future directions

artículo científico publicado en 2003

Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals

artículo científico publicado en 2016

Neoadjuvant Therapy for Early-Stage Breast Cancer: A Model for Individualizing Outcomes and Tailoring Locoregional and Systemic Therapy

Neoadjuvant chemotherapy for operable breast cancer: is this the future?

artículo científico publicado en 2003

Neoadjuvant nab-paclitaxel in the treatment of breast cancer

artículo científico publicado en 2016

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

artículo científico publicado en 2015

Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer

artículo científico publicado en 2008

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer ⬇️

artículo científico publicado el 1 de octubre de 2003

Omitting Surgery in Complete Responders After Neoadjuvant Chemotherapy: The Quest Continues

artículo científico publicado en 2018

Optimizing Surgical Management of the Axilla After Neoadjuvant Chemotherapy: An Evolving Story

scientific article published on 30 May 2018

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

artículo científico publicado en 2012

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

artículo científico publicado en 2005

Past, present, and future challenges in breast cancer treatment

artículo científico publicado en 2014

Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature

artículo científico publicado en 2012

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination

artículo científico publicado en 2019

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ

artículo científico publicado en 2004

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

artículo científico publicado en 2014

Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer

scientific article published on 14 April 2020

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

artículo científico publicado en 2015

Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy.

artículo científico publicado en 2017

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random

artículo científico publicado en 2004

Phase II trial of a doxorubicin/docetaxel doublet for locally advanced and metastatic breast cancer: results from national surgical adjuvant breast and bowel project trial BP-57.

artículo científico publicado en 2004

Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.

artículo científico publicado en 2002

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.

artículo científico publicado en 2016

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

artículo científico publicado en 2013

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. ⬇️

artículo científico publicado en 2012

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

artículo científico publicado en 2013

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

artículo científico publicado en 2008

Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience

scientific article published in 2001

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials

scientific article published on 01 May 2006

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer

artículo científico publicado en 2009

Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials

artículo científico publicado en 2003

Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncolog

scientific article published on 23 May 2016

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.

artículo científico publicado en 2008

Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer.

artículo científico publicado en 2004

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy

artículo científico publicado en 2009

Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project

artículo científico publicado en 2007

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis

scientific article published on 03 May 2018

Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors

artículo científico publicado en 2011

Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors

artículo científico publicado en 2007

Sentinel lymph node biopsy after neoadjuvant systemic therapy

artículo científico publicado en 2003

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

artículo científico

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

artículo científico publicado en 2010

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

artículo científico publicado en 2006

Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider

artículo científico publicado en 2012

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy

artículo científico publicado en 2016

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference

artículo científico publicado en 2008

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

scientific article published on 01 August 2019

Tailoring loco-regional therapy with neoadjuvant chemotherapy: another step in the right direction

artículo científico publicado en 2004

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less

artículo científico publicado en 2002

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

artículo científico publicado en 2007

The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.

artículo científico publicado en 2016

The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value?

artículo científico publicado en 2017

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

artículo científico publicado en 2003

The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project

artículo científico publicado en 2008

The importance of systemic therapy in minimizing local recurrence after breast-conserving surgery: the NSABP experience

artículo científico

The landmark surgical trials of the National Surgical Adjuvant Breast and Bowel Project

artículo científico publicado en 2006

Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy

artículo científico publicado en 2015

Timing of determining axillary lymph node status when neoadjuvant chemotherapy is used

artículo científico

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

artículo científico publicado en 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

artículo científico publicado en 2019

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

artículo científico publicado en 2019

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

artículo científico publicado en 2014

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

artículo científico publicado en 2005

Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations

artículo científico publicado en 2022

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 30 November 2018

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda